Epstein Secrets

rs." Senate Appropriations Chairman Shelby told reporters, "I think we're not going anywhere. A lot of talk, no action." The Washington Post (10/22, Werner, Stein, 14.2M) says some Senate Republicans are "growing increasingly frustrated" with Mnuchin "as he makes what they see as unacceptable compromis

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

e. A lot of talk, no action." The Washington Post <https://vvww.washingtonpost.com/us-policy/2020/10/22/trump-congress-coronavirus-bailout/> (10/22, Werner, Stein, I4.2M) says some Senate Republicans are "growing increasingly frustrated" with Mnuchin "as he makes what they see as unacceptable compromis

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

rs." Senate Appropriations Chairman Shelby told reporters, "I think we're not going anywhere. A lot of talk, no action." The Washington Post (10/22, Werner, Stein, 14.2M) says some Senate Republicans are "growing increasingly frustrated" with Mnuchin "as he makes what they see as unacceptable compromis

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug